is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 103,000 colleagues serve people in more than 160 countries.
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.
A global leader in in vitro diagnostics for more than 55 years, bioMérieux has always been driven by a pioneering spirit and unrelenting commitment to improve public health worldwide.
The Company is present in 44 countries and serves more than 160 countries with the support of a large network of distributors. It provides diagnostic solutions that improve patient health and ensure consumer safety.
At Illumina, their goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for them to deliver innovative, flexible, and scalable solutions to meet the needs of their customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.
Headquartered in Changsha, the company has built the new Industrial Park in Shanghai to create a production base for precise and intelligent molecular diagnostic systems and an important international hub, and set up branches or affiliates in nearly 20 cities, including Beijing, Guangzhou, Chongqing and Xi'an.
The company has developed a series of internationally leading core technologies and more than 400 products with performance exceeding the advanced level at home and abroad. All of the new technologies and products have lead the domestic industry to catch up with the international advanced level, and is now breaking the monopoly of imports and promoting the application of gene technology from individual departments to multiple departments in medical institutions, from high-end laboratories in large hospitals to all levels of hospitals including primary medical institutions, and from a few fields to all scenarios.
Seegene, Inc. is an in-vitro diagnostics (IVD) company that has been turning concepts into products through its pioneering R&D activities. Founded in Seoul in 2000 and with subsidiaries in Rockville, Maryland, USA and Eschborn, Germany, Seegene has developed innovative technology platforms including ACP™ (Annealing Control Primer), DPO™ (Dual Priming Oligonucleotide), and READ™ (Real Amplicon Detection).
With these cutting-edge molecular diagnostic (MoDx) technologies applied to diagnostic kits and other tools, Seegene has enhanced the sensitivity and specificity of PCR (polymerase chain reaction) to unprecedented levels. Seegene provides multiplex PCR products which target and detect genes of multiple pathogens simultaneously, saving testing time and cost. Seegene will continue to set new standards in MoDx and provide new, cost effective innovations.
We are Over 250 laboratories and 150 imaging units and with abroad
catalogue of more than 6,500 diagnostic tests, Unilabs is a leading European
provider of clinical laboratory testing and medical diagnostic imaging
services. Headquartered in Geneva, Switzerland the Unilabs Group serves private
and public healthcare providers, local governments, pharmaceutical companies
and the general public. The company employs more than 12,700 people worldwide,
successfully operates laboratory and medical diagnostic imaging facilities in
As a biotechnology company, Vazyme is committed to research and development both in technology and products focusing on functional proteins, such as enzymes, antigens, antibodies, and polymer organic materials. Relying on self-established critical generic technology platform, Vazyme successively marched into various business area: biological research, in vitro diagnosis (IVD), bio-pharmaceutical and so on. Moreover, our company is regarded as one of the few domestic R&D innovative enterprises that have capabilities of both independent and controllable upstream technology development and terminal product production. With “biochip” made in China, Vazyme is ready to provide source power for biotechnology industry.
AIM FOR PERFECTION IS THE ONLY WAY TO REACH IT. We are an Italian leading laboratory equipment manufacturer that has been producing laboratory products for medical technology since 1979.We have been successful year after year by manufacturing medical laboratory equipment constantly improved through a hard work. We like what we do and we do it well. This is possible because we want to offer our customers not only high quality medical lab equipment, but experience, professionalism and the broadest guarantees, too.
National Reference Laboratory (NRL) is focused on increasing the quality, spectrum, coverage and overall efficiency of laboratory testing in the UAE and the region. As a Mubadala Healthcare provider, it implements international best-practice reference-laboratory processes and aims to set the benchmark for quality standards in the region.NRL offers a comprehensive menu of tests, expanded in response to the needs of the region and providing a complete solution for all clinical testing needs in an efficient and high-quality environment. Of the 7.5+ million tests performed annually, 98% are done in house, allowing for greater quality control and reducing both turnaround time and logistics-related costs compared with other referral laboratories.
ME (Medical Electronics or Medical Engineering) is the union of medicine and engineering. ME is a common abbreviation in recent years but the founders of Nihon Kohden began working in medical electronics around 1945, long before this phrase was born.
The neuromuscular tissue of a small bird was the impetus behind the founding of Nihon Kohden. The late Dr. Yoshio Ogino, founder of Nihon Kohden, was doing research in electrical engineering when one day he happened to see an experiment involving stimulation of the neuromuscular tissue of a small bird. He was struck by the wonder of biology and remarked that “to measure part of a living body requires several hundred times the sensitivity and at least two decimal places more than the equipment developed by the leading electrical engineering experts in Japan.”
BioPerfectus, a public listed company at Shanghai Stock Exchange (SSE:688399), is one of the leading molecular diagnostic solution manufacturers in global in-vitro diagnostics market since 2010. With headquarter located in Taizhou, branch offices sited in Shanghai, Xi’an and Beijing, Bioperfectus is pioneering in molecular diagnostics market with our products ranging from real time PCR kits, nucleic acid extraction systems, rapid tests and automation laboratory devices etc...
Since the inception of International Sales and Marketing Division in June, 2020, under the authorization of international renowned public health organizations and institutions, our products have been distributing in over 50 countries all over the world and about to come to cover more countries in the near future. Young and passionate, Bioperfectus people are working steadily and firmly to achieve our dream to create a healthier future for our next generations.
With its unparalleled expertise and know-how in the transfusion sector, DIAGAST aims at facilitating the healthcare professionals work by guaranteeing a higher speed and a better safety in terms of blood grouping. Our core business is immuno-haematology, our strength is innovation, our ambition is internationally growing, our treasure is our people!
HORIBA Medical designs, develops and distributes worldwide, in vitro diagnostic systems mainly destined for biological analysis in medical laboratories. These automated analyzers meet the needs of various users including patients, doctors, private laboratories, clinics and university hospitals. HORIBA expertise in in vitro diagnostics is one of the most respected in hematology worldwide and contribute today to the health of tomorrow.
Asian Hospital & Healthcare Management is a quarterly publication from Ochre Media Pvt. Ltd. It is the leading healthcare title in print and digital versions serving the information needs of key executives from the world’s leading healthcare providers. Asian Hospital & Healthcare Management covers important issues and trends shaping the future of the healthcare industry across Asia and rest of the world. Asian Hospital & Healthcare Management offers . . . Dedicated, reliable and accurate coverage of the industry’s progress and Incisive analysis to help its readers make informed decisions to stay ahead of the competition.
EYE OF RIYADH provides effective digital marketing solutions for campaigns and events targeting Saudi Arabia and other GCC.
www.eyeofriyadh.com is one of the most popular website in the GCC among citizen, residents , tourists and investors who are seeking for information and wish to explore the opportunities in the region.